China Health Industries Stock Performance
| CHHE Stock | USD 0.20 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.56, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, China Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding China Health is expected to be smaller as well. At this point, China Health Industries has a negative expected return of -0.51%. Please make sure to confirm China Health's information ratio, as well as the relationship between the skewness and day median price , to decide if China Health Industries performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days China Health Industries has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| Begin Period Cash Flow | 44.3 M |
China |
China Health Relative Risk vs. Return Landscape
If you would invest 28.00 in China Health Industries on December 24, 2024 and sell it today you would lose (8.00) from holding China Health Industries or give up 28.57% of portfolio value over 90 days. China Health Industries is currently does not generate positive expected returns and assumes 2.9867% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of pink sheets are less volatile than China, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
China Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as China Health Industries, and traders can use it to determine the average amount a China Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1703
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CHHE |
Estimated Market Risk
| 2.99 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.51 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average China Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Health by adding China Health to a well-diversified portfolio.
China Health Fundamentals Growth
China Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of China Health, and China Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Pink Sheet performance.
| Return On Equity | -0.0186 | |||
| Return On Asset | -0.021 | |||
| Current Valuation | (25.17 M) | |||
| Shares Outstanding | 65.54 M | |||
| Price To Earning | 4.02 X | |||
| Price To Book | 0.28 X | |||
| Price To Sales | 1,000,000 X | |||
| Revenue | 267 | |||
| EBITDA | 479.53 K | |||
| Cash And Equivalents | 44.79 M | |||
| Cash Per Share | 0.68 X | |||
| Total Debt | 6.76 M | |||
| Debt To Equity | 0.16 % | |||
| Book Value Per Share | 0.61 X | |||
| Cash Flow From Operations | 2.12 M | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 50.75 M | |||
| Retained Earnings | 32.92 M | |||
| Current Asset | 31.62 M | |||
| Current Liabilities | 5.98 M | |||
About China Health Performance
By analyzing China Health's fundamental ratios, stakeholders can gain valuable insights into China Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if China Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if China Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company is based in Harbin City, the Peoples Republic of China. China Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 45 people.Things to note about China Health Industries performance evaluation
Checking the ongoing alerts about China Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for China Health Industries help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China Health generated a negative expected return over the last 90 days | |
| China Health has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 267. Net Loss for the year was (353.95 K) with loss before overhead, payroll, taxes, and interest of (1.48 K). | |
| About 31.0% of the company shares are held by company insiders |
- Analyzing China Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Health's stock is overvalued or undervalued compared to its peers.
- Examining China Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Health's pink sheet. These opinions can provide insight into China Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for China Pink Sheet analysis
When running China Health's price analysis, check to measure China Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Health is operating at the current time. Most of China Health's value examination focuses on studying past and present price action to predict the probability of China Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Health's price. Additionally, you may evaluate how the addition of China Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |